Related Experiment Video
Updated: May 1, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
Management of non-melanoma skin cancer in solid organ transplant recipients
F Specchio1, R Saraceno1, S Chimenti1
1Department of Medicine, University of Rome, Tor Vergata, Italy.
Abstract:
Non-melanoma skin cancer (NMSC) is the most frequent cancer observed in solid organ transplant recipients (SOTR). Early diagnosis, patient education, and modification of immunosuppression are effective measures for reduction of NMSC incidence. Many risk factors have been identified, including age at transplantation, fair skin, type of immunosuppressive drugs, cumulative sun exposure, viral infections, and various genetic markers. Skin self-examination and photoprotection should be encouraged in all transplanted patients. Long-term skin surveillance, early diagnosis and aggressive treatment of any suspicious lesion, reduction of immunosuppressive therapy, and conversion to mammalian target-of-rapamycin (m-TOR) inhibitors can be also effective measures for reduction of NMSC incidence.
Insights
Non-melanoma skin cancer (NMSC) is common in solid organ transplant recipients (SOTR). Early detection, patient education, and modifying immunosuppression are key to reducing NMSC incidence and improving outcomes.
Area of Science:
- Oncology
- Transplantation Medicine
- Dermatology
Background:
- Non-melanoma skin cancer (NMSC) is the most prevalent malignancy in solid organ transplant recipients (SOTR).
- Identified risk factors for NMSC in SOTR include age, skin type, immunosuppressive drug regimens, sun exposure, viral infections, and genetic markers.
Discussion:
- Proactive measures such as patient education, skin self-examination, and diligent photoprotection are crucial for managing NMSC risk.
- Modifying immunosuppressive therapy, including potential conversion to mammalian target-of-rapamycin (m-TOR) inhibitors, is a viable strategy to mitigate NMSC development.
Key Insights:
- Early diagnosis and aggressive treatment of suspicious skin lesions are paramount in SOTR.
- Personalized risk assessment considering individual factors is essential for effective NMSC prevention strategies.
Outlook:
- Continued research into optimal immunosuppression protocols and targeted NMSC prevention strategies for SOTR is warranted.
- Long-term skin surveillance programs are vital for early detection and improved prognosis in this high-risk population.
Related Concept Videos
Kidney Transplant III: Nursing Management
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Cell-mediated Immune Responses

